Table 2.

Cancer malignancy-related EV contents.

	Proteins	miRNAs	lncRNAs	Other
Carcinogenesis		let-7 [25]		EBER2 [26]
		miR-23a, miR-155 [27]
Proliferation	CLIC1 [28]	miR-410 [29]	TU399 [30]
	EphA2 [31]	miR-142-3p [32]	lncRNA-VLDLR [33]
	L1CAM [34]	miR-95 [35]	lncRNA-H19 [36]
	ZIP4 [37]	miR-30e [38]	EWSAT1 [39]
		hypoxia-induced miR-155 [40]
		miR-365 [41]
		miR-130b-3p [42]
		miR-497 [43]
Angiogenesis	Rac1, PAK2 [44]	miR-584-5p [45]
	VEGF90K [46]	miR-23b, miR-320b [47]
	angiopoietin-2 [48]	miR-23a [49]
	laminin γ2 [50]	miR143-3p, miR145-5p [51]
		miR-141-3p [52]
		miR-81b-5p [53]
		miR-4488 [54]
		miR-10a-5p [55]
		le-7b-5p [56]
Metastasis	TTLL4 [57]	miR-370-3p [58]	HLA-F-AS1 [59]	orphan RNA [60]
	PKM2 [61]	miR-181c [19]	HUCL [62]
		miR-30a-3p [63]
		miR-185-2p [64]
		MSC-miR222 [65]
		miR-30e [38]
		miR-23b [66]
		miR-193a [67]
		miR-622 [62]
		miR-224-5p [68]
Escape from immune system	PD-1 [69,70]	miR-222 [65]
Chemotherapeutic stress	ALK [71]	miR-30b-3p [72]	H19 [73]
	Vasconcelos, Chitinase 3-like-1 and fibronectin [74]		VLDLR [33,75]
			HOTPIT [76]
			RP11-838N2.4 [77]
			PART1 [78]
			SNHG14 [79]